Dr. Reddy's Launches Generic Version of Durezol in the US
01/27/2023
Following FDA approval, Dr. Reddy’s Laboratories announced the US launch of "Dr. Reddy’s Difluprednate Ophthalmic Emulsion 0.05%," a therapeutic generic equivalent to Durezol (Difluprednate Ophthalmic Emulsion 0.05%; Novartis), according to a company news release.
Durezol is a topical corticosteroid indicated for the treatment of inflammation and pain associated with ocular surgery, and the treatment of endogenous anterior uveitis.
Dr. Reddy’s Difluprednate Ophthalmic Emulsion 0.05% is available in 5 ml bottles in case packs of 24.